Fursultiamine
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596312

CAS#: 804-30-8

Description: Fursultiamine is a compound used for therapy of thiamine deficiency. It’s phosphorylated metabolites may be administered as multivitamin preparations. Fursultiamine has been identified as a drug candidate against prostate cancer from the aspect of somatic cell reprogramming and may be useful as a therapeutic tool in number of human neurological diseases.


Chemical Structure

img
Fursultiamine
CAS# 804-30-8

Theoretical Analysis

MedKoo Cat#: 596312
Name: Fursultiamine
CAS#: 804-30-8
Chemical Formula: C17H26N4O3S2
Exact Mass: 398.14
Molecular Weight: 398.540
Elemental Analysis: C, 51.23; H, 6.58; N, 14.06; O, 12.04; S, 16.09

Price and Availability

Size Price Availability Quantity
25mg USD 305
50mg USD 515
100mg USD 845
Bulk inquiry

Synonym: Fursultiamine; Judolor; Linamin; EINECS 212-357-1; Tetrahydrofurfuryl thiamine disulfide; TTFD;

IUPAC/Chemical Name: (E)-N-((4-amino-2-methylpyrimidin-5-yl)methyl)-N-(5-hydroxy-3-(((tetrahydrofuran-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide

InChi Key: JTLXCMOFVBXEKD-FOWTUZBSSA-N

InChi Code: InChI=1S/C17H26N4O3S2/c1-12(16(5-6-22)26-25-10-15-4-3-7-24-15)21(11-23)9-14-8-19-13(2)20-17(14)18/h8,11,15,22H,3-7,9-10H2,1-2H3,(H2,18,19,20)/b16-12+

SMILES Code: O=CN(CC1=CN=C(C)N=C1N)/C(C)=C(SSCC2OCCC2)\CCO

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 398.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Nozaki S, Mawatari A, Nakatani Y, Hayashinaka E, Wada Y, Nomura Y, Kitayoshi T, Akimoto K, Ninomiya S, Doi H, Watanabe Y. PET Imaging Analysis of Vitamin B(1) Kinetics with [(11)C]Thiamine and its Derivative [(11)C]Thiamine Tetrahydrofurfuryl Disulfide in Rats. Mol Imaging Biol. 2018 Mar 20. doi: 10.1007/s11307-018-1186-y. [Epub ahead of print] PubMed PMID: 29560588.

2: Park WS, Lee J, Hong T, Park G, Youn S, Seo Y, Lee S, Han S. Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations. Clin Ther. 2016 Oct;38(10):2277-2285. doi: 10.1016/j.clinthera.2016.08.009. Epub 2016 Oct 1. PubMed PMID: 27707509.

3: Xiong XY, Liu L, Wang FX, Yang YR, Hao JW, Wang PF, Zhong Q, Zhou K, Xiong A, Zhu WY, Zhao T, Meng ZY, Wang YC, Gong QW, Liao MF, Wang J, Yang QW. Toll-Like Receptor 4/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage. Circulation. 2016 Oct 4;134(14):1025-1038. Epub 2016 Aug 30. PubMed PMID: 27576776.

4: Doi H, Mawatari A, Kanazawa M, Nozaki S, Nomura Y, Kitayoshi T, Akimoto K, Suzuki M, Ninomiya S, Watanabe Y. Synthesis of (11)C-Labeled Thiamine and Fursultiamine for in Vivo Molecular Imaging of Vitamin B1 and Its Prodrug Using Positron Emission Tomography. J Org Chem. 2015 Jun 19;80(12):6250-8. doi: 10.1021/acs.joc.5b00685. Epub 2015 Jun 1. PubMed PMID: 25984933.

5: Fung E, Sugianto P, Hsu J, Damoiseaux R, Ganz T, Nemeth E. High-throughput screening of small molecules identifies hepcidin antagonists. Mol Pharmacol. 2013 Mar;83(3):681-90. doi: 10.1124/mol.112.083428. Epub 2013 Jan 4. PubMed PMID: 23292796; PubMed Central PMCID: PMC3583499.

6: Suzuki Y, Itoh H, Abe T, Nishimura F, Sato Y, Takeyama M. Comparison of the effects of pantethine and fursultiamine on plasma gastrointestinal peptide levels in healthy volunteers. Biol Pharm Bull. 2011;34(10):1640-3. PubMed PMID: 21963510.

7: Hills JI, Golub MS, Bettendorff L, Keen CL. The effect of thiamin tetrahydrofurfuryl disulfide on behavior of juvenile DBA/2J mice. Neurotoxicol Teratol. 2012 Mar;34(2):242-52. doi: 10.1016/j.ntt.2011.07.006. Epub 2011 Jul 24. PubMed PMID: 21816221.

8: Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice. Brain. 2010 May;133(Pt 5):1342-51. doi: 10.1093/brain/awq069. Epub 2010 Apr 12. PubMed PMID: 20385653.

9: Masuda H, Matsumae H, Masuda T, Hatta H. A thiamin derivative inhibits oxidation of exogenous glucose at rest, but not during exercise. J Nutr Sci Vitaminol (Tokyo). 2010;56(1):9-12. PubMed PMID: 20354340.

10: Nozaki S, Mizuma H, Tanaka M, Jin G, Tahara T, Mizuno K, Yamato M, Okuyama K, Eguchi A, Akimoto K, Kitayoshi T, Mochizuki-Oda N, Kataoka Y, Watanabe Y. Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats. Nutr Res. 2009 Dec;29(12):867-72. doi: 10.1016/j.nutres.2009.10.007. PubMed PMID: 19963160.

11: Irifune K. [Effect of Alinamin F and Kakkontou on mucoid Pseudomonas aeruginosa chronic lower respiratory tract infection]. Nihon Kokyuki Gakkai Zasshi. 2009 Mar;47(3):218-21. Japanese. PubMed PMID: 19348269.

12: Ishikawa Y, Miyagi M, Matsumoto T, Watanabe N, Tojo Y, Hiroi N, Kuboki K, Yoshino G, Tsubota T, Yoshihara K. [Beriberi heart failure caused by a retort pouch diet menu]. Nihon Naika Gakkai Zasshi. 2008 Oct 10;97(10):2552-4. Japanese. PubMed PMID: 19051749.

13: Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacol. 2008 Jun 12;8:10. doi: 10.1186/1471-2210-8-10. PubMed PMID: 18549472; PubMed Central PMCID: PMC2435522.

14: Tao H, Kitagawa N, Kako Y, Yamanaka H, Ito K, Denda K, Koyama T. A case of anorexia nervosa with Marchiafava-Bignami Disease that responded to high-dose intravenous corticosteroid administration. Psychiatry Res. 2007 Nov 15;156(2):181-4. PubMed PMID: 17933499.

15: Miyanari A, Kaneoke Y, Noguchi Y, Honda M, Sadato N, Sagara Y, Kakigi R. Human brain activation in response to olfactory stimulation by intravenous administration of odorants. Neurosci Lett. 2007 Aug 9;423(1):6-11. Epub 2007 Jul 5. PubMed PMID: 17658690.

16: Ohmori S, Kataoka M, Koyama H. Stability of cyanocobalamin in sugar-coated tablets. Int J Pharm. 2007 Jun 7;337(1-2):161-8. Epub 2007 Jan 9. PubMed PMID: 17300886.

17: Koike H, Watanabe H, Inukai A, Iijima M, Mori K, Hattori N, Sobue G. Myopathy in thiamine deficiency: analysis of a case. J Neurol Sci. 2006 Nov 15;249(2):175-9. Epub 2006 Aug 22. PubMed PMID: 16920153.

18: Miyanari A, Kaneoke Y, Ihara A, Watanabe S, Osaki Y, Kubo T, Kato A, Yoshimine T, Sagara Y, Kakigi R. Neuromagnetic changes of brain rhythm evoked by intravenous olfactory stimulation in humans. Brain Topogr. 2006 Spring;18(3):189-99. Epub 2006 Mar 1. PubMed PMID: 16544208.

19: Sekiyama S, Takagi S, Kondo Y. Peripheral neuropathy due to thiamine deficiency after inappropriate diet and total gastrectomy. Tokai J Exp Clin Med. 2005 Sep;30(3):137-40. PubMed PMID: 16285603.

20: Kawano H, Koide Y, Toda G, Yano K. ST-segment elevation of electrocardiogram in a patient with Shoshin beriberi. Intern Med. 2005 Jun;44(6):578-85. PubMed PMID: 16020883.